These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2633393)

  • 1. [Leukinferon in the treatment of severe forms of acute hepatitis B].
    Botsvadze ESh; Kuznetsov VP; Gogichaĭshvili ShSh
    Ter Arkh; 1989; 61(11):50-4. PubMed ID: 2633393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selected indicators of hepatitis B in the blood serum during the first few days of hospitalization of patients with acute viral hepatitis].
    Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
    Ann Univ Mariae Curie Sklodowska Med; 1987; 42():83-7. PubMed ID: 3154900
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection.
    Stancek D; Blaskovicová H; Hajnická V; Husár K; Holenová Z; Mathernová V; Sudová J; Laktis K; Spanárová V
    Acta Virol; 1987 May; 31(3):234-42. PubMed ID: 2888287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of different forms of B and delta hepatitis with interferon preparations].
    Botsvadze ESh; Kuznetsov VP; Aleksishvili MM; Gogichaĭshvili ShSh
    Ter Arkh; 1991; 63(11):61-3. PubMed ID: 1810067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Titers of selected indicators of hepatitis B in the blood of patients with acute viral hepatitis].
    Rzeszowska G; Mazurek E; Mierzejewska I; Fijałka-Rymar M; Ignaciuk A
    Ann Univ Mariae Curie Sklodowska Med; 1987; 42():89-94. PubMed ID: 3154901
    [No Abstract]   [Full Text] [Related]  

  • 6. Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illness.
    Stancek D; Fuchsberger N; Borecký L; Kotuliaková M; Hrúzik J; Sylvanová E; Sudová J
    Acta Virol; 1988 Mar; 32(2):148-52. PubMed ID: 2899961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral markers of hepatitis.
    Velasco M
    Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study].
    Hess G; Weber C; Rossol S; Voth R; Drees N; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1988 Jul; 26(7):380-7. PubMed ID: 3223006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon therapy in chronic hepatitis B and delta infection in children].
    Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
    Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study on the clinico-serologic course of acute hepatitis B and hepatitis B with delta co-infection].
    Castro Iglesias A; Pedreira JD; Rodríguez Lozano J; Sánchez Mozo MP; Alonso C; Amigo Fernández EJ
    Med Clin (Barc); 1989 Mar; 92(10):364-7. PubMed ID: 2716385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of a treatment with a thymus extract (thymostimulin) in acute viral hepatitis B in drug-dependent patients].
    Corridori S; Trespi G; Baldini E; Renzetti I; Calderon W
    Boll Ist Sieroter Milan; 1984; 63(6):519-28. PubMed ID: 6242017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis].
    Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal immunomodulation in chronic hepatitis type B with double filtration plasmapheresis.
    Fujikawa M; Tomita A; Nakata S; Matuura Y; Azechi H; Saibara T; Onishi S; Yamamoto Y
    Prog Clin Biol Res; 1990; 337():341-4. PubMed ID: 2352990
    [No Abstract]   [Full Text] [Related]  

  • 14. Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon.
    Hess G; Meyer zum Büschenfelde KH
    Immunobiology; 1986 Sep; 172(3-5):255-61. PubMed ID: 3643162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukinferon in the treatment of patients with acute viral hepatitis b].
    Golban TD; Cheshin SG; Kuznetsov VP; Farber NA; Beliaev DL; Kirzhner LS; Babaiants AA; Vasina VI
    Klin Med (Mosk); 1994; 72(3):27-9. PubMed ID: 7990347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of viral hepatitis. b) Anti-virus agents].
    Matsushima T
    Hokkaido Igaku Zasshi; 1984 May; 59(3):238-44. PubMed ID: 6479842
    [No Abstract]   [Full Text] [Related]  

  • 17. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of studying the HBe system in the prognosis of patients with acute and chronic viral hepatitis Be].
    Perisić-Savić M; Nastić-Mirić D
    Srp Arh Celok Lek; 1983; 111(9-10):1343-50. PubMed ID: 6681452
    [No Abstract]   [Full Text] [Related]  

  • 19. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of severe forms of viral hepatitis with injections of human leukocytic interferon].
    Kvitashvili MA; Kuznetsov VP; Pokrovskiĭ VI
    Ter Arkh; 1982; 54(9):28-32. PubMed ID: 6983735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.